Next Article in Journal
Mechanistic Insights into Cytokine Antagonist-Drug Interactions: A Physiologically Based Pharmacokinetic Modelling Approach with Tocilizumab as a Case Study
Previous Article in Journal
An Editorial on the Special Issue “Where Are We Now and Where Is Cell Therapy Headed?”
Previous Article in Special Issue
Engineered Exosomes Carrying Super-Repressor IκB Reduced Biliary Atresia-Induced Liver Fibrosis in Minipig and Mouse Models
 
 
Article

Article Versions Notes

Pharmaceutics 2025, 17(7), 895; https://doi.org/10.3390/pharmaceutics17070895
Action Date Notes Link
article pdf uploaded. 9 July 2025 16:07 CEST Version of Record https://www.mdpi.com/1999-4923/17/7/895/pdf-vor
article supplementary file uploaded. 9 July 2025 16:07 CEST - https://www.mdpi.com/1999-4923/17/7/895#supplementary
article xml file uploaded 10 July 2025 05:24 CEST Original file -
article xml uploaded. 10 July 2025 05:24 CEST Update https://www.mdpi.com/1999-4923/17/7/895/xml
article pdf uploaded. 10 July 2025 05:24 CEST Updated version of record https://www.mdpi.com/1999-4923/17/7/895/pdf
article html file updated 10 July 2025 05:26 CEST Original file https://www.mdpi.com/1999-4923/17/7/895/html
Back to TopTop